Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Pepticom Ltd.
Jerusalem, Israel
B
1-10 Employees
2011
Key takeaway
Pepticom focuses on advancing peptide therapeutics by designing novel peptide drug candidates through innovative biocomputational AI software, which optimizes the discovery process and reduces development risks and costs. Their mission is to enhance access to these therapeutics, ultimately driving forward 21st-century medicine.
Reference
Core business
Pepticom – Pepticom
Luxembourg Bio Technologies Ltd.
Nes Ziona, Israel
B
11-50 Employees
2008
Key takeaway
The company specializes in peptide synthesis, offering a range of products and reagents that enhance the efficiency and yield of peptide, oligonucleotide, and nanoparticle synthesis. They emphasize their partnership with Luxembourg Bio Technologies, which is known for its innovative peptide synthesis reagents.
Reference
Product
TL-2017-COMU-Azapeptides - Luxembourg Bio Technologies
TL-2017-COMU-Azapeptides Request an Information or Quotation Request InformationRequest Information
Entera Bio
Jerusalem, Israel
B
11-50 Employees
2010
Key takeaway
The company is developing innovative oral tablet therapies for protein and peptide replacement, aimed at providing patients with a healthier, injection-free alternative for managing chronic diseases. Their focus on high unmet clinical needs in the delivery of protein therapies positions them as a leader in this therapeutic area.
Reference
Core business
Home - EnteraBio
We are a clinical stage, global company, focused on high unmet clinical needs where oral delivery of a protein therapy can significantly improve the standard of care. We are developing first-in-class, daily tablet protein and peptide replacement therapies, designed for patients to live healthier and injection-free, as they manage their chronic diseases. Our goal is for our small, oral protein tablets to change treatment outcomes for patients globally.
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Mapi Pharma
Ness Ziona, Israel
B
11-50 Employees
2008
Key takeaway
The company is focused on developing improved extended-release formulations of existing drugs, including GLP-1 peptides for long-acting injectable therapies. Their innovative approach enhances patient compliance and treatment adherence, particularly in therapeutic areas like neuropathic pain, epilepsy, schizophrenia, and bipolar disorder.
Reference
Product
Products | Mapi Pharma
PolyPid
Drom HaSharon Regional Council, Israel
B
51-100 Employees
2008
Key takeaway
PolyPid is a clinical-stage biopharmaceutical company specializing in developing novel therapies that enhance surgical outcomes. Their proprietary PLEX technology allows for localized and controlled delivery of medications, targeting conditions such as infection, pain, inflammation, and cancer over extended periods.
Reference
Core business
PolyPid - Optimized Therapeutics
ABOUT US We are a global clinical-stage bio-pharmaceutical company focused on developing, manufacturing and commercializing novel, locally administered therapies to improve surgical outcomes. Our PLEX (Polymer-Lipid Encapsulation matriX) technology is a unique platform that is anchored in the surgical site to provide controlled and continuous delivery of medications. Our product candidates are designed to deliver medications […]
1E Therapeutics
Rishon LeZion, Israel
B
51-100 Employees
2020
Key takeaway
1E Therapeutics is pioneering the development of programmable oligonucleotide therapeutics aimed at precisely silencing disease-causing RNAs, which could be relevant to advancements in peptide therapeutics by highlighting innovative approaches to targeting diseases at the molecular level.
Reference
Core business
The future of therapeutic RNA silencing
Tarom Applied Technologies
Drom HaSharon Regional Council, Israel
B
11-50 Employees
1989
Key takeaway
Mimotopes Pty Ltd is a leading company in the peptide sector, specializing in the synthesis of custom peptides using advanced solid-phase techniques. Their offerings include a wide range of peptide lengths, purities, and quantities, making them well-equipped to meet diverse research and therapeutic needs.
Reference
Product
Mimotopes - Tarom Applied technologies
Custom peptides Mimotopes Pty Ltd is an industry leader in the peptide and discovery chemistry sector. Mimotopes’ custom peptides are synthesized in modern, automated synthesizers using advanced solid phase techniques. The value in using Mimotopes custom peptides is not only that we offer a wide range of peptide lengths, purities and quantities.
Lipomedix
Jerusalem, Israel
B
- Employees
2011
Key takeaway
LipoMedix is a development-stage company that is advancing an innovative cancer therapy using liposome delivery of a patented prodrug of mitomycin-C, which offers distinct advantages over conventional treatments. Their focus on developing safer and more effective therapies highlights their commitment to improving cancer treatment outcomes.
Reference
Product
LipoMedix - Pipeline
Peregrine Ventures
Or Yehuda, Israel
B
1-10 Employees
2001
Key takeaway
Peregrine is focused on advancing medical innovation through strategic investments in life sciences. Their portfolio company, ExoProTher, is developing a pioneering oncology therapeutics delivery platform that targets cancers with TP53 mutations, utilizing exosomes to restore natural tumor suppression.
Reference
Product
ExoProTher - Peregrine
pharma & biotech Linkedin-in Twitter Globe ExoProTher Medical is developing a first-in class oncology therapeutics delivery platform targeting cancers with mutation in gene TP53- the most frequently observed genetic alteration in human. It uses exosomes, natural nanoparticles produced by most living cells, to deliver healthy p53 and restore the body’s natural tumor suppression function with […]
Immunity Pharma
Jerusalem, Israel
B
- Employees
2007
Key takeaway
Immunity Pharma is focused on developing innovative compounds that stimulate therapeutic cell-signaling processes, which may be relevant for treating neurodegenerative diseases.
Reference
Core business
Home - Immunity Pharma
Technologies which have been searched by others and may be interesting for you:
The Peptide Therapeutics industry in Israel is characterized by a vibrant ecosystem that includes cutting-edge research institutions, innovative startups, and established pharmaceutical companies. Key considerations for those exploring this field involve understanding the regulatory landscape, which is governed by the Israel Ministry of Health and aligns closely with international standards to ensure safety and efficacy. Challenges such as high development costs and lengthy clinical trial processes can impact timelines and profitability. However, opportunities abound due to Israel's advanced biotechnology sector, which fosters collaboration between academia and industry, leading to significant breakthroughs in peptide-based therapies. Environmental concerns, particularly regarding sustainable manufacturing practices, are increasingly important as the industry seeks to minimize its ecological footprint. The competitive landscape is dynamic, with numerous players vying for market share, emphasizing the need for robust intellectual property strategies. Additionally, the global market relevance of peptide therapeutics is growing, driven by rising demand for targeted therapies in areas such as oncology and metabolic disorders. Thus, potential investors and stakeholders should be well-informed about these factors, as they greatly influence the success and viability of companies within the Israeli peptide therapeutics sector.
Some interesting numbers and facts about your company results for Peptide Therapeutics
| Country with most fitting companies | Israel |
| Amount of fitting manufacturers | 139 |
| Amount of suitable service providers | 43 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1989 |
| Youngest suiting company | 2020 |
Some interesting questions that has been asked about the results you have just received for Peptide Therapeutics
What are related technologies to Peptide Therapeutics?
Based on our calculations related technologies to Peptide Therapeutics are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Peptide Therapeutics?
The most represented industries which are working in Peptide Therapeutics are Other, Medical, Biotechnology, Pharmaceuticals, Healthcare
How does ensun find these Peptide Therapeutics Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.